Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Oksana Veselova"'
Autor:
Marina Palkeeva, Irina Studneva, Alexander Molokoedov, Larisa Serebryakova, Oksana Veselova, Michael Ovchinnikov, Maria Sidorova, Oleg Pisarenko
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 109, Iss , Pp 1556-1562 (2019)
N-terminal fragments of galanin (2–11) and (2–15) are critical for binding to GalR1-3 receptors, members of the G-protein-coupled receptor superfamily, and are involved in myocardial protection against ischemia/reperfusion (I/R) injury. This stud
Externí odkaz:
https://doaj.org/article/8c7de67e93af4efc868e2271aa231ebf
Autor:
Maria Sidorova, Alexander A. Timoshin, Irina Studneva, M. V. Ovchinnikov, L. I. Serebryakova, A. S. Molokoedov, A. A. Az’muko, Oksana Veselova, Oleg I. Pisarenko, Pal'keeva Me
Publikováno v:
International Journal of Peptide Research and Therapeutics. 27:2039-2048
Natural and chemically modified N-terminal galanin fragments (WTLNSAGYLLGPHA-OH (G1) and WTLNSAGYLLGPβAH-OH (G2), respectively) reduce functional and metabolic disturbances in the heart during experimental ischemia and reperfusion. The aim of this w
Autor:
Oksana Veselova, Irina Studneva, Igor Dobrokhotov, Marina Pal’keeva, Alexander Molokoedov, Maria Sidorova, Oleg Pisarenko
Publikováno v:
International Journal of Peptide Research and Therapeutics. 28
Autor:
Arthur A. Bahtin, Irina Studneva, Galina G. Konovalova, Vadim Z. Lankin, Oksana Veselova, Oleg I. Pisarenko
Publikováno v:
Acta Naturae
The use of the anticancer drug doxorubicin (Dox) is limited by its cardiotoxic effect. The aim of this work was to study the effect of a new synthetic agonist of the galanin receptor GalR1-3 [Ala14, His15]-galanine (215) (G) on the metabolism, antiox
Publikováno v:
Pflügers Archiv - European Journal of Physiology. 471:583-593
Disturbed homeostasis of nitric oxide (NO) is one of the causes of myocardial ischemia/reperfusion (I/R) injury during open-heart surgery. This study was designed to explore mechanisms of action of dinitrosyl iron complexes with reduced glutathione (
Autor:
Oleg I. Pisarenko, Maria Sidorova, Oksana Veselova, Irina Studneva, A. S. Molokoedov, Pal'keeva Me, L. I. Serebryakova, M. V. Ovchinnikov, Radik Gataulin
Publikováno v:
Peptides. 111:127-131
Agonists and antagonists for galanin receptor subtypes GalR1-3 can be used as putative therapeutics targets for the treatment of various human diseases. However, effects of galanin and its N-terminal fragments on myocardial ischemia/reperfusion injur
Autor:
M. V. Ovchinnikov, L. I. Serebryakova, A. S. Molokoedov, Pal'keeva Me, Oleg I. Pisarenko, Irina Studneva, Oksana Veselova, Maria Sidorova
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 109, Iss, Pp 1556-1562 (2019)
N-terminal fragments of galanin (2–11) and (2–15) are critical for binding to GalR1-3 receptors, members of the G-protein-coupled receptor superfamily, and are involved in myocardial protection against ischemia/reperfusion (I/R) injury. This stud
Publikováno v:
Journal of Physiology and Biochemistry. 74:283-290
The maintenance of nitric oxide (NO) bioavailability has been recognized as an important component of myocardial protection during cardiac surgery. This study was designed to evaluate the efficacy of using two NO-donating compounds in cardioplegia an
Autor:
Alexander A. Timoshin, Pal'keeva Me, Maria Sidorova, A. A. Az’muko, A. S. Molokoedov, Oleg I. Pisarenko, Oksana Veselova, Irina Studneva, M. V. Ovchinnikov, L. I. Serebryakova
Publikováno v:
International Journal of Peptide Research and Therapeutics. 27:2049-2049
Autor:
Maria Sidorova, Pal'keeva Me, Frederic Boal, Oleg I. Pisarenko, Oksana Kunduzova, Hélène Tronchère, Andrei Timotin, Irina Studneva, Oksana Veselova, Mathieu Cinato, Aleksander Molokoedov, Shul'zhenko Vs, L. I. Serebryakova
Publikováno v:
Oncotarget
// Oleg Pisarenko 1, * , Andrei Timotin 2, 3, * , Maria Sidorova 1 , Irina Studneva 1 , Valentin Shulzhenko 1 , Marina Palkeeva 1 , Larisa Serebryakova 1 , Aleksander Molokoedov 1 , Oksana Veselova 1 , Mathieu Cinato 2, 3 , Frederic Boal 2, 3 , Helen